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ABSTRACT
Objective: Gold nanoparticles (AuNPs) are highly useful for drug delivery, but their application is limited by their stability as they readily aggregate. 
This issue can be prevented by adding a stabilizing agent such as resveratrol (RSV), which is a polyphenol derived from plants, that is used to prevent 
cancer. Therefore, we propose a novel method to prepare stable RSV-conjugated nanoparticles modified with polyethylene glycol (RSV-AuNP-PEG).
Methods: In the first step, the Turkevich method was used to synthesize the AuNPs. Then, PEG was added as stabilizer agent and conjugated with RSV. 
The synthesized conjugates were characterized using ultraviolet-visible spectrophotometry, Fourier transform infrared spectroscopy, particle size 
analysis, and high-performance liquid chromatography.
Results: The obtained RSV-AuNP-PEG had a particle size of 83.93 nm with a polydispersity index (PDI) of 0.562 and formed a translucent purple-red 
fluid in solution. The zeta potential was −22.9 mV, and the highest entrapment efficiency was 75.86±0.66%. For comparison, the RSV-AuNP solution 
was purple and turbid, the particle size was 51.97 nm with a PDI of 0.694, and the zeta potential was −24.6 mV. The stability test results showed that 
the storage stability of RSV-AuNP-PEG was better than that of AuNP-RSV. Further, the RSV-AuNP-PEG was shown to be most stable in 2% bovine serum 
albumin (BSA) while the AuNP-RSV was most stable in 2% BSA in phosphate-buffered saline pH 7.4.
Conclusion: These results show that modification of RSV-conjugated AuNPs with PEG effectively prevents their aggregation in storage, but only in 
certain mediums.
Keywords: Gold nanoparticles, Polyethylene glycol, Resveratrol, Stability.
INTRODUCTION
Nanoparticles have several advantages such as improvement in the 
intracellular infiltration, circulation time of the drug, and enhanced 
hydrophobic solubility [1]. Nanoparticles are usually <100 nm in size. 
They consist of different biodegradable materials such as natural or 
synthetic polymers, lipids, or metals [2]. Gold nanoparticles (AuNPs) 
have been widely developed as a multifunctional platform for various 
biomedical applications [3] such as biosensing systems, cancer 
therapies, drug delivery, and pharmaceuticals [4]. AuNPs have core 
sizes ranging from 1 to 150 nm. In general, AuNPs are synthesized by 
chemical reduction using chloroauric acid (HAuCl4) as the reducing 
agent. AuNPs offer a combination of chemical, physical, optical, and 
electronic properties that are beneficial in various fields. However, 
AuNPs are unstable because of their high surface energy, which 
can cause them to aggregate. Aggregation can occur particularly in 
biological applications because of the high ionic strengths of many 
biological fluids and non-specific interactions between nanoparticles 
and biomolecules such as proteins or DNA [5]. This aggregation of 
AuNPs prevents their penetration into target cells. Particle aggregation 
can be prevented by adding a stabilizing agent [6] such as polyethylene 
glycol (PEG), which decreases the surface energy and Van der Waal’s 
interactions, thereby reducing aggregation [7].
AuNPs can be conjugated with drugs such as resveratrol (RSV). RSV 
is a polyphenol compound found in plants, usually in its trans-RSV 
(3,5,4′-trihydroxystilbene) form [8], that has the ability to prevent 
cancer [9]. RSV can effectively inhibit the growth of breast cancer 
cells by inhibiting several molecules, including MMP-9, COX-2, NF-
αB, AP-1, and PI3K/Akt dan ERK. This effect is stronger with AuNPs 
than with the same dose of RSV alone [10]. In this study, AuNPs were 
conjugated with RSV as a drug model and modified with PEG as a 
stabilizing agent. The obtained RSV-AuNPs-PEG were evaluated in 
terms of its physical stability and particle size and characterized 
by ultraviolet (UV)-visible spectrophotometry, Fourier transform 




RSV (Sigma-Aldrich, USA), ethanol (Merck, Germany), chloroauric 
acid (Sigma Aldrich, USA), PEG bisamine (molecular weight 3.000; 
Sigma-Aldrich, USA), sodium citrate (Merck, Germany), phosphate-
buffered saline (PBS; Sigma-Aldrich, USA), cysteine (Sigma-Aldrich, 
USA), bovine serum albumin (BSA; Sigma-Aldrich, USA), and sodium 
hydroxide, methanol (Merck, Germany) were used. The solvents and 
other chemical reagents were of analytical grade.
Synthesis of AuNP-RSV with PEG modification
15 ml of a 1 mM aqueous solution of HAuCl4.3H2O was heated to ±95°C 
while stirring. Then, 423 µl of a 130 mM sodium citrate aqueous 
solution was rapidly added to the solution while stirring. The solution 
changed from pale yellow to colorless, then changed to dark blue, and 
finally to deep red-burgundy after a few minutes. The solution was 
stirred and heated for 15 min after the addition of sodium citrate, then 
removed from heat and cooled at room temperature while stirring. 
2.175 ml of a 0.04 mM aqueous PEG bisamine was added while stirring. 
Next, 3.425 ml of aqueous RSV was added dropwise to the solution, 
and stirring was continued at 150 rpm for 2 h at room temperature to 
obtain RSV-conjugated AuNPs-PEG (RSV-AuNPs-PEG). In addition, the 
RSV-AuNPs solution without PEG was also made (RSV-AuNPs).
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Characterization
Physical appearance
The physical appearance of RSV-AuNPs-PEG was observed, including 
the shape and color of the solution.
Spectral analyses
Absorbance and wavelength measurements were obtained with a UV-
visible spectrophotometer over a wavelength range of 400–600 nm. 
The infrared spectrum was evaluated by FTIR spectroscopy over 
a wavenumber range of 400–4000 cm−1 on dried samples ground 
homogeneously with KBr.
Particle size distribution, polydispersity index (PDI), and zeta potential
The particle size distributions and zeta potentials of RSV-AuNPs-PEG 
and RSV-AuNPs were measured by dynamic light scattering (DLS) 
using a particle size analyzer with a computerized system (Malvern, 
Zetasizer).
Entrapment efficiency measurements
1.5 ml of RSV-AuNP-PEG was ultracentrifuged at 12,000 rpm for 1 h. 
The precipitate was discarded, and the supernatant was collected and 
filtered through a 0.22 µm-pore filter. The entrapment efficiency was 
measured by the indirect method using HPLC and calculated using the 
following formula:




A C18 column was used to perform chromatography with the obtained 
samples. The mobile phase was Aqua Pro, which contains acetonitrile 
and glacial acetic acid. The injection volume was 20 µl, and the flow rate 
was 1.5 ml/min. The eluted fractions were analyzed using a UV-visible 
306 nm detector.
Stability test in various mediums
1 ml of each sample was re-dispersed in each 0.5 ml PBS pH 7.4, PBS pH 4, 
0.9% NaCl, 2% BSA, and 1% cysteine. The stability test was conducted 
over the course of 1 month. Samples were collected daily during the 
1st week and at 3-day intervals during the 3 weeks. Each sample was 




RSV-AuNPs-PEG was synthesized with 1 mM HAuCl4.3H2O and 130 nM 
sodium citrate as the reducing agent. Sodium citrate reduced Au3+ to Au0 
by reacting with H2O to form citric acid [11]. The reaction is as follows.
2HAuCl4+3C6H8O7 (citric acid)→2Au+3C5H6O5 (3-acid ketoglutarate) 
+8HCl+3CO2
The color change of the solution from pale yellow to colorless to dark 
blue then to deep red-burgundy or purple-reddish after a few minutes 
confirms the reduction from Au3+ to Au0 as the purple-reddish color 
arises from surface plasmon resonance, which is characteristic of 
metal nanoparticles. The reduction reaction can be further confirmed 
based on new absorbance in the wavelength range of 500–550 nm on 
the absorbance spectrum [12]. The absorbance spectra in this study 
showed increased absorption at 528.50 nm, indicating that AuNPs were 
successfully formed (Fig. 1).
When 0.04 mM PEG bisamine was added to the solution, the purple-
reddish was still formed, indicating that the nanoparticles remained 
stable when modified with PEG. PEG may reduce the attractive 
forces between particles and decrease the surface energy by steric 
stabilization, thereby preventing the aggregation that often occurs with 
AuNPs.
The RSV-AuNPs-PEG solution was also translucent with no odor, in 
contrast to the RSV-AuNPs solution without PEG. The lack of turbidity is 
characteristic of the colloidal dispersion of AuNPs and indicates that the 
RSV-AuNPs-PEG nanoparticles were small in size and homogeneously 
dispersed.
Absorbance properties
HAuCl4 exhibited strong absorbance at 287 nm. This can be attributed 
to the charge transfer between metal and the chlorine-based ligand. 
When the HAuCl4 by the sodium citrate, the absorbance peak at 287 nm 
disappeared and a new absorbance peak formed at 529 nm. As shown 
in Fig. 2, RSV-AuNPs-PEG and RSV-AuNPs absorbed light at the same 
wavelength, 529 nm, but the shape of the spectra differed. RSV-AuNP-
PEG exhibited stronger absorbance than RSV-AuNPs, indicating that 
these nanoparticles were smaller [13]. RSV-AuNPs-PEG also had a 
relatively narrow absorption peak around 520 nm, while RSV-AuNPs, 
with larger particles, had a wider absorption peak [14]; this means 
Fig. 1: Ultraviolet-visible spectra of gold nanoparticles, showing a 
peak at 528.50 nm
Fig. 2: Ultraviolet-visible absorbance spectra of (a) 1 mM HAuCl4, 
(b) a 12 ppm polyethylene glycol (PEG) solution, (c) 10 ppm 
resveratrol (RSV), (d) RSV-gold nanoparticles (AuNPs), (e) RSV-
AuNPs-PEG
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that the solution was monodisperse due to the stabilizing effect of 
PEG-bisamine, which prevented particle aggregation.
Particle size distribution, PDI, and zeta potential
The particle size, zeta potential, and PDI of each sample are shown in 
Table 1. DLS was used to determine the particle size; the measurement 
with this technique not only depends on the core size but also on the 
surface structure [15]. The particle size measurements show that the 
particles were nanoscale sized (1–100 nm) [16]: RSV-AuNPs-PEG had 
a particle size of 83.93 nm while RSV-AuNPs had a particle size of 
51.97 nm. These results confirm that the RSV-AuNPs-PEG particles were 
larger than the RSV-AuNPs particles. This difference can be attributed 
to the PEG caps on the RSV-conjugated AuNPs.
Another important physical property is the PDI, which reflects the 
degree of heterogeneity of particles. The particle size distribution was 
measured using a DLS particle size analyzer (Malvern Zetasizer). PDIs 
closer to zero imply that the particle size is more homogeneous; PDIs 
<0.7 are considered to be good [17]. The PDI of RSV-AuNPs was 0.694 
and that of RSV-AuNPs-PEG was 0.562.
The zeta potentials of RSV-AuNPs and RSV-AuNPs-PEG were measured. 
Zeta potentials >+30 mV or <−30 mV are considered to be good [13]. 
The zeta potential of RSV-AuNPs was −24.6 mV and that of RSV-AuNPs-
PEG was −22.9 mV. While both zeta potential values were >−30 mV, 
that of the RSV-AuNPs-PEG was larger than that of the RSV-AuNPs. 
This is because the PEG modification decreases the zeta potential [18], 
which may be because PEG leads to steric stabilization that does 
not significantly affect the electrokinetic potential in the colloidal 
dispersion.
Infrared spectra
The FTIR spectra of AuNPs, RSV, RSV-AuNPs, and RSV-AuNPs-PEG are 
shown in Fig. 3. RSV exhibited prominent bands at wavenumbers of 
3380–2925 and 2834–2456 (attributed to O-H), 1613 (attributed to 
C=C alkene), 1600, 1475 (C=C aromatic), and 833 cm−1 (meta-para 
substitution). Bands were observed at 833 (meta-para substitution), 
1475, and 1600 cm−1 (C=C aromatic) in RSV-AuNPs and RSV-AuNPs-
PEG, implying that there may be RSV in samples. The PEG-bisamine 
exhibited prominent bands at wavenumbers of 3621 (N–H), 2864 
(C–H), 1298 (C–O), 1131 (C–N), and 1600 cm-1 (C=C). However, the 
bands at 1600 (C=C alkene), 1100 (C-N), and 3621 cm-1 (N-H) were 
not observed in the spectrum of RSV-AuNPs-PEG. Therefore, it was 
suspected there a bond had formed with the N group due to the PEG-
bisamine.
Entrapment efficiency
The standard calibration data for the entrapment efficiency (Fig. 4) 
were fitted to a curve with the equation of y=92620x−28703 (y=peak 
area; x=concentration) with r=0.9995. The chromatogram showed 
time retentions of both standard RSV and the RSV in the sample were 
about 14 min (Figs. 4 and 5). The entrapment efficiency analysis with 
an indirect method showed RSV concentration that entrapment in RSV-
AuNPs-PEG in 3 times analysis was 76.59%, 75.29%, and 75.70%. The 
entrapment efficiency in this sample was 75.86±0.6%.
Table 1: Size, PDI, and zeta potential of each sample
Formula Size (nm) PDI Zeta potential (mV)
RSV-AuNPs 51.97 0.694 −22.9
RSV-AuNPs-PEG 83.93 0.562 −24.6
PDI: Polydispersity index, RSV: Resveratrol, AuNPs: Gold nanoparticles, 
PEG: Polyethylene glycol
Fig. 4: Chromatogram of the resveratrol standard
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Stability in various media
Stability tests were conducted to evaluate the possibility of aggregated 
AuNPs in the body, which is important because unstable AuNPs would 
be dangerous for the body. Another purpose of these measurements was 
to evaluate which media can distribute the AuNPs. Samples were stored 
for 4 weeks in different mediums then evaluated using a UV-visible 
spectrophotometer as absorbance decreases indicate larger particle 
sizes [13]. The physical appearance was observed, and the absorbance 
changes were evaluated in terms of the maximum wavelength shift and 
full width at half maximum (FWHM). The absence of changes in the 
absorbance and wavelength of the UV-visible spectrum indicates that 
the AuNPs were stable [14]. A low FWHM indicates monodispersity 
while a high FWHM indicates polydispersity [19]; thus, the wider the 
FWHM is, the more unequal the sizes of the colloidal AuNPs, which may 
indicate that the AuNPs aggregated. The results are shown in Fig. 6 and 
summarized in Table 2.
Stability of control (without addition medium)
The control sample was sampled without redispersing at any of the 
media. The UV-visible absorbance and wavelength of the RSV-AuNPs-
PEG solution decreased between days 0 and 28, but the change was not 
significant. On the other hand, those of RSV-AuNPs fluctuated over the 
4 weeks. This result demonstrates that RSV-AuNPs-PEG was more stable 
than RSV-AuNPs. In addition, the shape of the absorbance spectrum of 
RSV-AuNPs-PEG was different from that of RSV-AuNPs in that it was 
relatively narrow. This difference was confirmed by the observation 
that the FWHM of RSV-AuNPs-PEG did not increase significantly over 
the experimental period, while that of RSV-AuNPs increased at each 
sampling time point. Furthermore, the absorbance bands of RSV-AuNPs 
shifted to longer wavelengths [20] compared with those of RSV-AuNPs-
PEG, indicating that it had a larger particle size. This finding implies 
that the RSV-AuNPs may have aggregated. This was supported by the 
observed precipitate formation on day 16. Based on these findings, it 
can be concluded that RSV-AuNPs-PEG was more stable in storage than 
RSV-AuNPs.
Stability in 1% cysteine
The addition of cysteine to the RSV-AuNPs-PEG solution caused an 
instant color change from purple-reddish to blue, which indicates that 
the solution was not stable in this medium. The UV-visible absorbance 
spectrum of this sample shows widening, indicating that the AuNPs had 
coagulated in this medium [14]. In addition, the spectrum also showed 
new absorbance at 680 nm, which occurs due to oscillating plasma 
dipoles when two metal particles of a colloid join and their plasma 
dipoles interact [20]. Similar observations were made with the RSV-
AuNPs, indicating that it was also unstable in the 1% cysteine medium. 
This instability can be attributed to the interactions between the AuNPs 
and the thiol groups in cysteine, which are stronger than the bonds 
between the PEG-bisamine and cause the AuNPs to aggregate.
Stability in 0.9% NaCl
The color of the RSV-AuNPs solution changed from reddish-purple to 
purple in the 0.9% NaCl medium, while that of the RSV-AuNPs-PEG 
solution changed from reddish-purple to blue, reflecting the instability 
of both samples in this medium. On day 1, both solutions became clear, 
and a precipitate was observed. In addition, at this time point, the 
absorbances of the AuNPs-RSV and RSV-AuNPs-PEG solutions decrease 
significantly, further demonstrating their instability. Comparing the 
FWHM values in the NaCl medium, the spectra of both solutions were 
wide on day 0. On the 1st day, the FWHM value could not be calculated 
because the line was almost 0 due to the instability in this medium. The 
observed instability can be attributed to the Na+ and Cl− ions causing 
the AuNPs to aggregate and precipitate according to the DLVO theory, 
which states that the coagulation of dispersed particles is explained 
in two forces: Van der Waals forces and repulsive electrostatic double-
layer forces [20].
Stability in 2% BSA
A stability test was conducted in a BSA medium because albumin is the 
most abundant protein in the body, accounting for 60% of the protein 
in human plasma. Therefore, the stability test in BSA can predict the 
stability of drug-conjugated AuNPs in human blood plasma in vitro [21]. 
The results show that RSV-AuNPs-PEG was initially stable, but the 
absorbance of the RSV-AuNPs-PEG solution decreased and shifted from 
525–526 nm to 523 nm on day 5. This finding was supported by the 
formation of a precipitate in the RSV-AuNPs-PEG solution on day 5. In 
contrast, the absorption of the RSV-AuNPs solution was more stable in 
the BSA. Furthermore, the FWHM of the RSV-AuNPs-PEG solution was 
greater on day 5 than on day 0, while that of the RSV-AuNPs solution 
did not change significantly, further confirming that RSV-AuNPs was 
more stable than RSV-AuNPs-PEG in this medium. The instability of 
RSV-AuNPs-PEG in this medium likely arose because PEG, which acts 
as a stabilizing agent, can also bind to proteins, leaving the AuNPs 
unstable leading to their aggregation, resulting in decreased and 
Fig. 5: Chromatogram of resveratrol in the sample
Fig. 6: Comparisons of the (a) absorbance, (b) wavelength, and (c) full width at half maximum for resveratrol-gold nanoparticles (RSV-
AuNPs)-polyethylene glycol and RSV-AuNPs over 1 month
a cb
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Day RSV-AuNPs RSV-AuNPs-PEG
(nm) Absorbance FWHM (nm) (nm) Absorbance FWHM (nm)
Control sample 0 529.00 2.094 83.219 529.00 2.433 58.581
1 539.50 1.920 83.592 531.00 2.426 58.56
2 527.00 1.991 90.904 530.00 2.471 58.186
3 535.50 1.803 106.49 530.00 2.456 58.064
4 528.50 1.750 104.38 529.00 2.450 58.045
5 529.00 1.637 110.35 529.50 2.416 57.159
6 535.00 1.493 123.51 531.50 2.413 57.261
7 534.50 1.374 128.34 530.00 2.340 57.225
10 532.50 1.277 131.9 530.00 2.331 57.207
13 534.50 1.208 136.65 529.00 2.230 57.782
16 620.50 0.607 204.02 530.00 2.112 58.21
19 - 0.000 - 529.00 2.073 58.279
22 - 0.000 - 529.00 2.057 57.782
25 - 0.000 - 528.50 2.025 59.294
28 - 0.000 - 530.00 2.001 58.652
1% Cysteine 0 529.00 0.028 241.37 638.5 0.91 199.8
1 - 0.000 - 677 0.126 234.93
2 - 0.000 - 665 0.066 202.4
3 - 0.000 - 543 0.057 254.28
4 - 0.000 - 665 0.042 344.72
5 - 0.000 - - 0.000 -
6 - 0.000 - - 0.000 -
7 - 0.000 - - 0.000 -
10 - 0.000 - - 0.000 -
13 - 0.000 - - 0.000 -
16 - 0.000 - - 0.000 -
19 - 0.000 - - 0.000 -
22 - 0.000 - - 0.000 -
25 - 0.000 - - 0.000 -
28 - 0.000 - - 0.000 -
0.9% NaCl 0 535.00 1.082 160.92 696.00 0.543 187.97
1 - 0.000 - - 0.000 -
2 - 0.000 - - 0.000 -
3 - 0.000 - - 0.000 -
4 - 0.000 - - 0.000 -
5 - 0.000 - - 0.000 -
6 - 0.000 - - 0.000 -
7 - 0.000 - - 0.000 -
10 - 0.000 - - 0.000 -
13 - 0.000 - - 0.000 -
16 - 0.000 - - 0.000 -
19 - 0.000 - - 0.000 -
22 - 0.000 - - 0.000 -
25 - 0.000 - - 0.000 -
28 - 0.000 - - 0.000 -
2% BSA 0 526.00 2.173 72.347 525.50 1.645 52.908
1 531.50 2.174 71.425 525.00 1.46 50.77
2 529.00 2.165 73.935 525.00 1.345 51.105
3 530.00 2.155 72.39 525.50 1.325 49.482
4 528.50 2.170 71.401 526.00 1.066 51.121
5 529.00 2.202 71.422 523.00 0.883 65.957
6 527.50 2.200 69.233 521.00 0.786 63.922
7 528.50 2.204 67.11 522.00 0.813 67.443
10 524.00 2.138 46.072 513.00 0.756 71.921
13 529.50 2.117 62.653 514.00 0.916 72.613
16 530.00 2.114 61.772 514.50 0.901 74.652
19 527.50 2.068 64.455 514.00 0.781 74.652
22 529.50 2.089 63.328 514.00 0.787 74.19
25 524.50 2.061 60.706 513.50 0.869 71.529
28 523.50 2.097 66.566 513.50 0.86 73.028
PBS pH 7.4 0 529.50 1.059 99.579 694.00 0.780 161.67
1 530.00 0.995 97.834 - 0.000 -
2 529.50 0.933 102.55 - 0.000 -
3 530.50 0.846 101.94 - 0.000 -
4 529.50 0.797 104.13 - 0.000 -
5 531.00 0.748 106.97 - 0.000 -
6 532.00 0.726 109.78 - 0.000 -
7 533.00 0.689 109.47 - 0.000 -
Table 2: RSV-AuNPs and RSV-AuNPs-PEG stabilities in various mediums
(Contd...)
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Day RSV-AuNPs RSV-AuNPs-PEG
(nm) Absorbance FWHM (nm) (nm) Absorbance FWHM (nm)
10 533.50 0.654 111.3 - 0.000 -
13 533.00 0.629 108.14 - 0.000 -
16 532.50 0.618 109.8 - 0.000 -
19 532.50 0.590 112.14 - 0.000 -
22 532.00 0.544 135.84 - 0.000 -
25 532.50 0.580 153.31 - 0.000 -
28 530.50 0.582 150.15 - 0.000 -
PBS pH 7.4 0 529.00 0.014 212.27 691 0.982 167.25
1 - 0.000 - 682 0.009 222.37
2 - 0.000 - - - -
3 - 0.000 - - - -
4 - 0.000 - - - -
5 - 0.000 - - - -
6 - 0.000 - - - -
7 - 0.000 - - - -
10 - 0.000 - - - -
13 - 0.000 - - - -
16 - 0.000 - - - -
19 - 0.000 - - - -
22 - 0.000 - - - -
25 - 0.000 - - - -
28 - 0.000 - - - -
RSV: Resveratrol, AuNPs: Gold nanoparticles, PEG: Polyethylene glycol, FWHM: Full width at half maximum, BSA: Bovine serum albumin, PBS: Phosphate-buffered saline
Table 2: (Continued)
shifted absorbance [21]. We used PEG 3000 in this study; thus it has 
been considered as a long-chain PEG. In a previous study, long-chain 
PEG in aqueous solutions is more capable of interacting with proteins 
than short-chain PEG [21] because it contains more binding sites. 
Hence, it can be concluded that RSV-AuNPs is stable for 28 days in 
2% BSA medium, but RSV-AuNPs-PEG became unstable on day 5 in 
this medium. This finding implies that PEG-modified particles are not 
suitable for in vitro applications.
Stability in PBS
Stability testing was conducted in PBS mediums of different pHs to 
determine the effect of pH on the AuNPs stability. pH change is one 
of the causes of aggregation in colloidal AuNPs solutions [20]. In this 
test, stability testing was performed at pH 7.4, which represents the 
pH of the body under normal circumstances, and pH 4, which mimics 
the environment of tumor tissue [22]. In the PBS pH 7.4 medium, RSV-
AuNPs was more stable than RSV-AuNPs-PEG, which indicates that the 
pH of the medium caused the dielectric modification of the RSV-AuNPs-
PEG, resulting in their aggregation. In contrast, the absorbance and 
wavelength of RSV-AuNPs did not decrease as significantly. Thus, the 
behavior of RSV-AuNPs-PEG may be derived from PEG-bisamine, which 
reacts with PBS. On the other hand, in the PBS pH four medium, both 
the RSV-AuNPs-PEG and RSV-AuNPs were unstable. Therefore, it can be 
presumed that the RSV will be readily released from nanoparticles in a 
tumor environment. The stability test results showed that RSV-AuNPs-
PEG was more stable over 28 days, while RSV-AuNPs was only stable 
for 19 days of storage. This difference can be attributed to the steric 
stabilization effects of PEG on the colloidal AuNPs.
CONCLUSION
The results of this study show that PEG modification of RSV-conjugated 
AuNPs prevents their aggregation in storage. However, this influence 
is only effective in some mediums. Although RSV-AuNPs-PEG was 
stable in BSA for 4 days, it was unstable in 1% cysteine, 2% BSA, 0.9% 
NaCl, and PBS pH 7.4. On the other hand, RSV-AuNPs were stable in 
BSA 2% and PBS pH 7.4 for 28 days but unstable on 1% cysteine, 0.9% 
NaCl, and PBS pH 4. RSV-AuNPs were more stable most mediums than 
RSV-AuNPs-PEG. This difference may have been due to the low PEG 
concentration used, short stirring time such that the citrate ions were 
not fully exchanged with PEG, or the effect of temperature when the 
PEG was added. Therefore, additional studies should be undertaken 
to optimize other parameters, such as the stirring time, temperature, 
and pH, which affect the formation of the RSV-AuNPs-PEG conjugate. In 
addition, increasing the concentration of PEG in the synthesis process 
may improve its stabilizing effects.
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